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The rate of renal synthesis of 1,25(OH) 2 D 3 is directly responsive to plasma levels of P i , growth hormone (GH), insulin-like growth factor I (IGF-I), parathyroid hormone (PTH), and calcitonin (CT; see Refs. 24, 36, and 41) . Regulatory feedback on 1␣-hydroxylase is provided by 1,25(OH) 2 D 3 by induction of 24-hydroxylase activity and thus conversion of 1,25(OH) 2 D 3 into less biologically active metabolites in its target tissues, including intestine, kidney, and bone (7, 52) . In the kidney, 24-hydroxylase activity is enhanced by 1,25(OH) 2 D 3 and downregulated by PTH (48, 62, 63) , whereas in the intestine, 24-hydroxylase is enhanced by 1,25(OH) 2 D 3 and downregulated by CT (3) .
The period of rapid growth is a formidable challenge for vitamin D 3 metabolism in preserving skeletal mineralization. There are few investigations in young intact animals that have studied the hormonal regulation of excessive vitamin D 3 with respect to the activity of 1␣-hydroxylase and 24-hydroxylase (4, 47, 57, 58) . However, these studies confined their measurements to single-moment observations, possibly because of technical limitations. Therefore, there is insufficient knowledge concerning the timedependent changes of vitamin D 3 metabolism during elevated dietary vitamin D 3 intake. Obtaining insight into the complexity of vitamin D 3 homeostasis in relation to its regulating hormones and enzymes requires large research animals for long-term studies on the effect of dietary vitamin D 3 supplementation. Dogs are of adequate size to allow for simultaneous and sequential sampling of blood and tissue material during the rapid growth period. Additional advantages are complete dependence on the dietary intake of vitamin D 3 (29) and thus easy regulation of the vitamin D 3 status without interpretation problems caused by seasonal variation of plasma vitamin D 3 metabolite concentrations.
To study the time-dependent changes and interactions of hormones implicated in Ca homeostasis during long-term dietary vitamin D 3 supplementation and their effect on in vivo regulation of 1␣-hydroxylase and 24-hydroxylase, a control group of dogs was investigated vs. an ample 100-fold vitamin D 3 -supplemented group for 18 wk immediately after partial weaning. Calciotropic and growth-regulating hormones were measured throughout the study. The influence of longterm vitamin D 3 supplementation on parathyroid chief cell and thyroid C cell function was evaluated by dynamic tests. Furthermore, the gene expression of renal 1␣-hydroxylase and 24-hydroxylase, and intestinal 24-hydroxylase, was determined, and the production and clearance rates of 1,25(OH) 2 D 3 were investigated.
MATERIALS AND METHODS

Animals and diets.
The Utrecht University Ethical Committee for Animal Care and Use approved all procedures. Sixteen Great Danes, originating from three different litters, were divided into the following two groups at 3 wk of age: a control group (n ϭ 9, CVitD) and a dietary vitamin D 3-supplemented group (n ϭ 7, HVitD). Pups were raised on an extruded diet formulated to be comparable in energy, Ca, and phosphate content (450 kcal, 9.5 g, and 7.5 g/100 g dry matter diet, respectively). The control diet was formulated to contain the recommended amount of 500 IU vitamin D 3/kg diet (1, 38) , whereas the supplemented vitamin D3 diet was formulated to contain a total of 50,000 IU vitamin D3/kg diet. Diets were analyzed for their vitamin D3 content (55) by a reference laboratory (TNO Nutrition and Food Research, Zeist, The Netherlands), and the analyzed vitamin D 3 content was 470 and 54,000 IU vitamin D3/kg diet for the CVitD and HVitD, respectively, with no detectable traces of ergocalciferol. From 3 until 6 wk of age, pups received their diet as a gruel in addition to the bitch milk and received dry diet exclusively later on. Body weight was measured biweekly, and food was provided at two times maintenance energy requirements of each dog (31) for the duration of the study.
Blood measurements. At 7, 10, 13, 16, and 19 wk of age, blood samples were collected after an overnight fast. Blood samples for the measurement of plasma total Ca and P i levels were transferred to heparin tubes, centrifuged, and measured according to standard procedures (Beckman Industries).
Blood samples for hormone analysis were immediately transferred to EDTA-coated tubes and placed on ice until centrifuged. Plasma was stored at Ϫ20°C until analysis. 2D3 was extracted from plasma using acetonitrile followed by a two-step solid-phase extraction (C 18 and silica gel cartridge; Waters Chromatography B. V. Etten, Leur, The Netherlands) and quantitatively determined by a radioreceptor assay based on the method described by Reinhardt et al. (44) and Hollis (28) with intraassay and interassay CV of 5.7 and 6.6%, respectively. PTH was measured using an immunoradiometric assay for intact PTH (Nichols Institute, San Juan Capistrano, CA; see Ref. 54). The detection limit was 1 ng/l. The intra-and interassay CV were at 40 ng/l for 3.4 and 5.6%, respectively, and at 266 ng/l for 1.8 and 6.1%, respectively. CT was measured after extraction with ethanol by a homologous RIA as described before (25) with a detection limit of 25 ng/l. The intra-and interassay CV at 175 ng/l were 15.3 and 15.4%, respectively, and at 670 ng/l 4.5 and 9.2%, respectively. GH was measured by a homologous RIA, as described previously (20) . The intraand interassay CV were 3.8 and 7.2%, respectively. Total IGF-I concentrations were measured by a heterologous RIA, as described previously (37), with intra-and interassay CV of 4.7 and 15.6%, respectively.
Dynamic tests on C cell and chief cell function. Tests were performed after overnight food deprivation with a week between tests to avoid reciprocal influences. Ca infusion tests were performed at 6, 12, and 18 wk of age, whereas EDTA infusion tests were performed at 7, 13, and 19 wk of age in all dogs.
In short, during the Ca stimulation tests, dogs were kept in a sitting position, and calcium gluconate (13.75 mg calcium gluconate/ml; Sandoz Pharma, Basel, Switzerland) was administered for 3-5 s through an indwelling catheter in the cephalic vein. The total dose was 0.28 ml calcium gluconate/kg body wt, equivalent to a dose of 2.52 mg Ca 2ϩ /kg body wt. Blood samples were taken by jugular venipuncture at Ϫ5, 0, 1, 2, 4, 8, and 16 min after the initiation of the Ca infusion.
During the EDTA infusion tests, dogs were kept in right lateral recumbency, and 30 mg Na3EDTA/kg body wt in 1 ml of 0.9% NaCl were administered at a constant infusion rate of 0.25 ml ⅐ kg body wt Ϫ1 ⅐ min Ϫ1 through an indwelling catheter in the cephalic vein. Blood samples were obtained through an indwelling catheter in the jugular vein at Ϫ5, 0, 1, 2, 4, 8, and 16 min after the initiation of the EDTA infusion. Dogs were monitored closely during the infusion for the occurrence of clinical and electrocardiographic signs of hypocalcemia.
Plasma PTH, CT, and Ca 2ϩ levels were determined at all time points. Blood samples for the analysis of Ca 2ϩ were collected anaerobically in heparinized syringes (PICO 50; Radiometer, Copenhagen, Denmark), placed in melting ice, and analyzed within 2 h after collection with the aid of an ionized calcium analyzer (ABL 605; Radiometer).
Preinfusion plasma levels of Ca 2ϩ , PTH, and CT measured at Ϫ5 and 0 min served as the baseline and were defined as Ca Baseline 2ϩ , PTHBaseline, and CTBaseline, respectively. Postinfusion maximal-response plasma levels were defined in the Ca infusion tests as Ca max 2ϩ , PTHmin, and CTmax and in the EDTA infusion tests as Ca min 2ϩ , PTHmax, and CTmin, respectively. In each group, the areas under the curve above zero and above baseline were calculated from the stimulated values. The mean response levels above zero (RL0) and above baseline (RLBaseline) were derived from the corresponding AUC corrected for the duration of the response (t, min), i.e., AUC/t.
The Ca set point for PTH release ( Ca Sfor PTH), i.e., the plasma Ca 2ϩ level that inhibits PTH secretion to 50% of its maximal stimulated value, was calculated according to the model described by Brown (9) . The parathyroid gland function was analyzed with a logistic model containing the four parameters equation: 
a . Using the PTHmax and PTHmin values from the data, z and thus z* can be calculated and by applying linear regression on the logarithmically transformed variables z* and x, the values of C and a can be determined. Plasma levels obtained after the completion of the EDTA infusion were excluded from the analysis, since this would cause hysteresis (10) . Because of the time delay in Ca 2ϩ -driven PTH secretion, values also obtained at t ϭ 1 min were not used.
After euthanasia, at 21 wk of age, both left and right thyroid and parathyroid glands were removed in total and fixed in 10% buffered formalin. After fixation, a longitudinal section was made, and the material was embedded routinely in paraffin. Sections were stained with hematoxylin and eosin for routine histological investigation and were examined blindly. Activity of the parathyroid glands was estimated from the cellular and nuclear size, aspect of the cytoplasma, and number of mitotic figures. The activity of the C cells was estimated histologically from the number of C cells, the cellular and nuclear size, and the aspect of cytoplasma.
1␣-Hydroxylase and 24-hydroxylase gene expression. Gene expression of 1␣-hydroxylase and 24-hydroxylase was determined at the middle and the end of the study in all dogs. At 10 wk of age, five duodenal forceps biopsies were taken under endoscopic guidance with the dog under general anesthesia. In addition, at 11 wk of age, two kidney biopsies were obtained with the aid of fine needle biopsy under guidance of echography with the dog under general anesthesia. At the end of the study, i.e., at 21 wk of age, the animals were killed with an overdose of pentobarbital sodium, and biopsies from the kidney and mucosa of the proximal duodenum were sampled. Kidney and intestinal biopsies were frozen immediately in liquid nitrogen and stored at Ϫ70°C until required for RNA isolation.
Frozen intestinal and kidney tissue sampled at the middle of the study was resuspended in Qiagen lysis buffer, homogenized using a Polytron, and centrifuged for 3 min at 5,000 g at room temperature. Frozen tissue sampled at 21 wk of age was ground in liquid nitrogen prefrozen cups of a microdismembrator (Micro-Dismembrator U; B. Braun Biotech International, Melsungen, Germany) using two cycles of 45 s at 2,200 rpm. Thirty milligrams of milled tissue (kidney or intestine) were resuspended in Qiagen lysis buffer and centrifuged for 3 min at 5,000 g at room temperature. The supernatant was applied to a Qiagen minicolumn (Qiagen, Hilden, Germany), and total RNA was isolated according to the manufacturer's protocol.
RNA was ethanol precipitated and resuspended in RNAsecure (1ϫ; Ambion, Austin, TX) that was activated at 60°C for 10 min. After DNase I treatment (DNAfree kit; Ambion), RNA was ethanol precipitated again and resuspended in 20 l RNase-free water. Total RNA (2 and 3 g) was used in a cDNA-synthesis reaction with 40 and 60 l final volume (Reverse Transcription System; Promega) according to the manufacturer's instructions for the material sampled at the middle and the end of the study, respectively.
Real-time PCR based on the high-affinity double-stranded DNA-binding dye SYBR green I (BMA, Rockland, ME) was performed in triplicate in a spectrofluorimetric thermal cycler (iCycler; Bio-Rad, Hercules, CA). Data were collected and analyzed with the provided application software. For each real-time PCR reaction, 1.67 l (of the 60-l stock) of cDNA were used in a reaction volume of 50 l containing 1ϫ PCR buffer, 2 mM MgCl 2, 1:100,000 dilution of SYBR green I, 10 nM fluorescein calibration dye (Bio-Rad), 200 M dNTPs, 20 pmol forward primer, 20 pmol reverse primer, and 1.25 units of AmpliTaq Gold DNA polymerase (Applied Biosystems, Roche, Branchburg, NJ). Cycling conditions were optimized for the reaction of each target gene. Primer pairs (Table 1) were designed using PrimerSelect software (DNAS-TAR, Madison, WI).
Melt curves (iCycler; Bio-Rad) and agarose gel electrophoresis were used to examine each sample for purity, and standard sequencing procedures (ABI PRISM 310 Genetic Analyzer; Applied Biosystems) were used to verify the analytical specificity of the PCR products. Standard curves constructed by plotting the log of the starting amount vs. the threshold cycle were generated using serial 10-fold dilutions of known amounts of PCR products (from a conventional PCR). The amplification efficiency, E (%) ϭ [10 (1/Ϫs) Ϫ 1] ϫ 100 (s ϭ slope), of each standard curve was determined and appeared to be Ͼ90% over a large dynamic range (6-8 orders of magnitude). For each experimental sample, the amounts of target (1␣-hydroxylase and 24-hydroxylase) and ␤-actin as endogenous reference were determined from the appropriate standard curve in an autologous experiment. The amount of target was divided by the amount of endogenous reference to obtain a normalized target value. Each of the normalized target values was divided by the normalized target value of the calibrator (i.e., CVitD) to generate n-fold relative expression levels. Statistical analysis. Statistical analyses were performed using SPSS for Windows 10.1 (SPSS). Homogeneity of variance was tested according to Levene. Differences between groups were analyzed by the two-sided Student's t-test. The AUC of the basal plasma PTH and CT levels were calculated for the duration of the study for both groups. Values were considered to be significant at P Ͻ 0.05. Results are presented as means Ϯ SE. For the analysis of the pre-and postinfusion plasma levels within the group, baseline values were compared with the corresponding maximal response values by a one-sided Student's t-test for paired data. Differences in RL 0, RLBaseline, and Ca Sfor PTH between groups were analyzed by the two-sided Student's t-test.
RESULTS
Dogs had good general health, grew well, and consumed the total amount of food that was offered daily. Consequently, energy and food intake per kilogram metabolic body weight (kg 0.75 ) did not differ between groups. HVitD consumed ϳ135 times more vitamin D 3 /kg body wt compared with CVitD. The mean growth rate per week for the entire study period was 1.5 Ϯ 0.4 and 1.6 Ϯ 0.3 kg body wt/wk of age for CVitD and HVitD, respectively, and was not significantly different between groups.
Blood measurements. Plasma Ca levels did not differ between groups for the duration of the study (Fig. 1) . Plasma P i levels did not differ between groups and ranged from 2. were 12-to 16-fold increased in HVitD vs. CVitD for the duration of the study (Fig. 1) . Plasma 1,25(OH) 2 D 3 levels did not differ between groups at 7 wk of age, whereas for the remainder of the study they were decreased significantly in HVitD vs. CVitD (Fig. 1) . Most basal plasma PTH levels and the PTH AUC were significantly lower in HVitD vs. CVitD for the duration of the study (Fig. 1) . Basal plasma CT levels were highly variable, being mainly increased in the beginning period of the study in HVitD vs. CVitD (Fig. 1) . The CT AUC for the duration of the study was increased significantly in HVitD vs. CVitD. Plasma GH and IGF-I levels did not differ between groups and increased and decreased with age from 19.7 Ϯ 2.4 to 6.6 Ϯ 1.1 g/l and from 216 Ϯ 24 to 360 Ϯ 27 g/l, respectively.
Ca and EDTA infusion tests. Plasma Ca Baseline 2ϩ levels did not differ between groups in the beginning (6 and 7 wk) and middle (12 and 13 wk) of the study (on average 1.52 Ϯ 0.03 mmol/l), whereas they were significantly increased at the end of the study (18 and 19 wk) in HVitD vs. CVitD (i.e., 1.54 Ϯ 0.01 vs. 1.48 Ϯ 0.04 mmol/l, respectively). Plasma PTH Baseline levels were significantly lower in all tests and at all ages in HVitD vs. CVitD (Fig. 1) . Plasma CT Baseline levels were increased significantly at 6 and 7 wk of age and were variably higher later on in the study in HVitD vs. CVitD (Fig. 1) .
During the Ca infusion tests at all ages and in both groups, plasma levels of Ca max 2ϩ , PTH min , and CT max were significantly different with respect to the preinfusion levels. The RL 0 of PTH was at all ages significantly lower in HVitD vs. CVitD, whereas the RL Baseline of PTH did not differ between groups ( Table 2 ). The RL 0 and RL Baseline of CT were significantly higher in HVitD vs. CVitD only at 6 and 12 wk of age (Table 2) .
During the EDTA infusion tests at all ages and in both groups, plasma levels of Ca min 2ϩ , PTH max , and CT min were significantly different with respect to the preinfusion levels. The RL 0 of PTH was lower in HVitD vs. CVitD only at 7 and 19 wk of age, whereas the RL Baseline of PTH was significantly lower in HVitD vs. CVitD only at 19 wk of age (Table 2 ). Both RL 0 and RL Baseline of CT were higher in HVitD vs. CVitD only at 7 wk of age ( Table 2) . The Ca S for PTH was significantly lower in HVitD vs. CVitD at the beginning and middle of the study, whereas is did not differ between groups at the end of the study (Fig. 2) .
There were no obvious histological differences with respect to the parathyroid glands and the C cell compartment of the thyroid between groups.
Gene expression levels of 1␣-hydroxylase and 24-hydroxylase. At all ages, gene expression levels of renal 1␣-hydroxylase, 24-hydroxylase, and intestinal 24-hydroxylase were increased significantly in HVitD vs. CVitD, respectively (Fig. 3 ). There were no age-dependent differences within each group.
MCR (Fig. 4) .
DISCUSSION
Dietary 135-fold vitamin D 3 supplementation during growth had striking influences on the main vitamin D 3 metabolites in plasma and was accompanied by hypoparathyroidism, lowered Ca S for PTH , and hypercalcitoninemia. Plasma P i , GH, and IGF-I levels could be excluded as differentially regulating factors, since they did not differ between groups, leaving Ca 2ϩ , PTH, CT, vitamin D 3 intake, and vitamin D 3 metabolites as the (47) . In HVitD, the 12-to 16-fold increased plasma 24,25(OH) 2 D 3 levels were attributed to the increased renal 24-hydroxylase activity indicated by the striking 10.5-and 6-fold increase of the renal 24-hydroxylase gene expression levels at both measure points compared with CVitD. Plasma (14) . In support, the significantly increased renal and intestinal 24-hydroxylase gene expression indicated upregulation of the 24-oxidation pathway. At the same time, in HVitD, the PR of 1,25(OH) 2 D 3 was increased significantly, being in accordance with the 9.3-and 8-fold increases in the renal 1␣-hydroxylase gene expression at both measure points compared with CVitD. Renal synthesis of 1,25(OH) 2 D 3 is regulated tightly by Ca, 1,25(OH) 2 D 3 , PTH, and CT (7, 35, 36) . Increased plasma Ca 2ϩ levels at the end of the study did not seem to affect the production of 1,25(OH) 2 D 3 in HVitD, whereas the decreased plasma 1,25(OH) 2 D 3 levels indicated withdrawal of homologous negative feedback on the production of 1,25(OH) 2 D 3 . Plasma PTH levels were decreased significantly for the duration of the study in HVitD and thus can be excluded as a relevant upregulating factor of the production of 1,25(OH) 2 D 3 (49) . Plasma CT levels were, however, at high levels in HVitD, being a potential upregulator of the production of 1,25(OH) 2 D 3 (49) . In accordance, Beckman et al. (4) hold increasing plasma CT levels during hypercalcemia responsible for stimulating the production of 1,25(OH) 2 D 3 . It seems conceivable to suggest that the stimulatory effect of CT on 1,25(OH) 2 D 3 production is an additional defensive mechanism in growing animals to maintain positive Ca balance required for optimal skeletal mineralization.
24-Hydroxylase is a potent key regulator. In hypervitaminosis, D 3 24-hydroxylase seems to play a counterregulating key role (3, 4) . 24-Hydroxylase has been reported to be upregulated by 1,25(OH) 2 D 3 at the transcriptional level (61) and downregulated by PTH (62, 63) , more so at the kidney level than at the intestinal level (48) and by CT at the intestinal level (3) . Relevant upregulators of 24-hydroxylase may have been the increased free plasma 1,25(OH) 2 D 3 levels, as well as 25(OH)D 3 , which has been reported to act directly on target organs of 1,25(OH) 2 D 3 both at supraphysiological (12) and physiological concentrations (16, 26) . Hypoparathyroidism in HVitD and thus reduction of the downregulatory effect of PTH on kidney 24-hydroxylase assured an active 24-hydroxylase pathway for the regulation of the circulating 25(OH)D 3 and 1,25(OH) 2 D 3 . Hypercalcitoninism resulted accordingly in HVitD in an increment of 24-hydroxylase gene expression of a smaller magnitude on an intestinal than on a renal level. In summary, the increased renal synthesis of 1,25(OH) 2 D 3 was provided with an effective means of its deactivation by upregulation of the 24-oxidation pathway in target organs (intestine and kidney), and consequently plasma 1,25(OH) 2 D 3 levels were lower in HVitD than in CVitD, as has been reported to occur in rats by Beckman et al. (4) . (8, 13) . At a lower Ca S for PTH , the production of PTH is not necessarily decreased, although increased free plasma 1,25(OH) 2 D 3 , the abundantly circulating 25(OH)D 3 , and increased plasma Ca 2ϩ levels have been reported to have an inhibiting effect on the production of PTH (50, 51) . Histological evaluation of the activity of the parathyroid glands at the end of the study did not show any obvious differences between HVitD and CVitD dogs. A modified demand for intact biologically active PTH may also have been achieved by adjustment of the parathyroid secretion profile toward an increased secretion of carbon-terminal fragments of PTH, as reported in hypercalcemic states or treatment with 1,25(OH) 2 D 3 (15) without necessarily a decrease in production of PTH.
Effects of hypervitaminosis D 3 on CT secretion. The principal regulator of CT secretion is the increase in plasma Ca 2ϩ levels (2) . Only in the beginning and middle of the study were the increased CT secretion and increased responsiveness of C cells to stimuli indicated by the significantly higher RL 0 and RL Baseline of CT in HVitD vs. CVitD during stimulation or depression of CT secretion. These findings were independent of the basal plasma Ca 2ϩ levels and indicated increased CT production with or without C cell hyperplasia (22, 30, 42) . However, C cell hyperresponsiveness seemed to be elapsing with the duration of the study, since the differences in CT secretion and responsiveness between groups were diminished at the end of the study. The latter was also verified by histological evaluation at the same time point. Responsiveness of the C cells to changes of the plasma Ca 2ϩ levels and the production of CT may be mediated by the extracellular CaR of C cells (11, 21) . It remains to be elucidated which positive regulator or mediator may have resulted in increased secretion of CT and responsiveness of the C cells in HVitD, including endocrine systems directly or indirectly connected to bone metabolism (45) . The biological significance of an increase in CT during states of positive Ca balance, as during growth, is mainly directed at avoiding hypercalcemia by decreasing osteoclastic resorption and enhancing deposition of Ca in bone (46) .
Conclusively, during 135-fold vitamin D 3 supplementation in growing dogs despite the increase in 1,25(OH) 2 D 3 production, plasma 1,25(OH) 2 D 3 levels were decreased as a result of an apparently even greater catabolism of 1,25(OH) 2 D 3 by 24-hydroxylase. Downregulation of the PTH secretion and hypercalcitoninism provided extra protection against hypercalcemia by cessation of bone resorption and thus reduction of the liberation of Ca. There was only a slight increase in plasma Ca 2ϩ levels at the end of the study, suggesting that the total burden of vitamin D 3 might have reached a critical stage. However, there was no clear shift toward a vitamin D 3 toxic state with the typical clinical signs of impaired growth, hypercalcemia and hyperphosphatemia, and kidney failure. In spite of the 135-fold vitamin D 3 supplementation, HVitD dogs grew well and retained normophosphatemia and normal plasma total Ca levels for most of the study. Efficient hormonal counteraction with a key role for 24-hydroxylase prevented the development of vitamin D 3 toxicosis during the course of the study.
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